Overall rank by patents
#29,047
of 49,997 tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 11 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08F (Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds).
The verdict
According to USPTO PatentsView, IGM ranks #29,047 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 11 technology areas.
USPTO PatentsView assignee plate
Corpus R29047 · Foreign Corporation #29,047 · 9 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL
Nearest grant-volume peer: ID Pharma Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
IGM Resins Italia S… · this assignee
48 score
3D Lighting… · lowest
7 score
What this shows IGM's Innovation Score is 48.4/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
IGM Resins Italia S.R.L. is a focused PatentsView assignee: 11 CPC subclasses with 88.9% of grants classified under C08F (Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2016. By volume, IGM sits between ID Pharma Co., Ltd. and Imaginalis S.R.L..
IGM Resins Italia S.R.L. shows 5 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ID Pharma Co., Ltd.
9 patents
IDM Global, Inc.
9 patents
Idsc Holdings LLC
9 patents
Ifco Systems GMBH
9 patents
Ihara Science Corporation
9 patents
Ii-vi Advanced Materials, LLC
9 patents
Iljin Electric Co., Ltd.
9 patents
Imaginalis S.R.L.
9 patents
IGM Resins Italia S.R.L.
9 patents
What this shows IGM holds 9 patents at rank #29,030, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #29,030 in granted patent volume.
Other assignees with the most granted patents in IGM's primary technology class.
IGM's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
48 Top 17% higher than 83% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 11.1% |
| 2017 | 1 | 11.1% |
| 2018 | 2 | 22.2% |
| 2022 | 2 | 22.2% |
| 2023 | 2 | 22.2% |
| 2024 | 1 | 11.1% |
Top 11 of 11 technology areas
Overall rank by patents
#29,047
of 49,997 tracked assignees
48.4 out of 100
What to do with this data
IGM Resins Italia S.R.L.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.